| Chundra Brown Brooks, FNP | |
|
658 N Chase St Ste 201, Athens, GA 30601-1960 | |
| (706) 353-2990 | |
| (706) 353-2992 |
| Full Name | Chundra Brown Brooks |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 11 Years |
| Location | 658 N Chase St Ste 201, Athens, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699116624 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN200229 (Georgia) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | RN200229 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Cancer And Blood Center, Llc | 0345293866 | 39 |
News Archive
Bruker Corporation today announced that it recently has received two significant orders of TANGO and MATRIX-I FT-NIR (Fourier transform near infrared) spectrometers from leading animal nutrition companies in the People's Republic of China
Self-management education programs for people with chronic obstructive pulmonary disorder (COPD) significantly decrease hospital admissions, researchers report in a new systematic review of studies.
High levels of anxiety and depression among medical doctors have been recorded in a new cross-country study that finds Italian doctors most likely to have experienced mental health symptoms during the pandemic.
Researchers in the University of Arizona's BIO5 Institute have entered into a collaboration with Johnson & Johnson Consumer & Personal Products and Janssen Biotech Inc. to leverage foundational discovery research aimed at determining environmental factors that underlie asthma and allergies.
Aerie Pharmaceuticals, a biotechnology company focused on the discovery and development of novel treatments for glaucoma, today announced positive results from a Phase 2a study of its Rho-kinase (ROCK) inhibitor, AR-12286. The study evaluated the safety, tolerability and efficacy of three different doses of AR-12286 in 88 patients with primary open angle glaucoma or ocular hypertension.
› Verified 9 days ago
| Entity Name | University Cancer & Blood Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346343761 PECOS PAC ID: 0345293866 Enrollment ID: O20050224000694 |
News Archive
Bruker Corporation today announced that it recently has received two significant orders of TANGO and MATRIX-I FT-NIR (Fourier transform near infrared) spectrometers from leading animal nutrition companies in the People's Republic of China
Self-management education programs for people with chronic obstructive pulmonary disorder (COPD) significantly decrease hospital admissions, researchers report in a new systematic review of studies.
High levels of anxiety and depression among medical doctors have been recorded in a new cross-country study that finds Italian doctors most likely to have experienced mental health symptoms during the pandemic.
Researchers in the University of Arizona's BIO5 Institute have entered into a collaboration with Johnson & Johnson Consumer & Personal Products and Janssen Biotech Inc. to leverage foundational discovery research aimed at determining environmental factors that underlie asthma and allergies.
Aerie Pharmaceuticals, a biotechnology company focused on the discovery and development of novel treatments for glaucoma, today announced positive results from a Phase 2a study of its Rho-kinase (ROCK) inhibitor, AR-12286. The study evaluated the safety, tolerability and efficacy of three different doses of AR-12286 in 88 patients with primary open angle glaucoma or ocular hypertension.
› Verified 9 days ago
| Entity Name | Hospital Physician Services - Southeast Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760410385 PECOS PAC ID: 5597774554 Enrollment ID: O20060419000545 |
News Archive
Bruker Corporation today announced that it recently has received two significant orders of TANGO and MATRIX-I FT-NIR (Fourier transform near infrared) spectrometers from leading animal nutrition companies in the People's Republic of China
Self-management education programs for people with chronic obstructive pulmonary disorder (COPD) significantly decrease hospital admissions, researchers report in a new systematic review of studies.
High levels of anxiety and depression among medical doctors have been recorded in a new cross-country study that finds Italian doctors most likely to have experienced mental health symptoms during the pandemic.
Researchers in the University of Arizona's BIO5 Institute have entered into a collaboration with Johnson & Johnson Consumer & Personal Products and Janssen Biotech Inc. to leverage foundational discovery research aimed at determining environmental factors that underlie asthma and allergies.
Aerie Pharmaceuticals, a biotechnology company focused on the discovery and development of novel treatments for glaucoma, today announced positive results from a Phase 2a study of its Rho-kinase (ROCK) inhibitor, AR-12286. The study evaluated the safety, tolerability and efficacy of three different doses of AR-12286 in 88 patients with primary open angle glaucoma or ocular hypertension.
› Verified 9 days ago
| Entity Name | Marcy Inpatient Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396154159 PECOS PAC ID: 0244555613 Enrollment ID: O20150205000737 |
News Archive
Bruker Corporation today announced that it recently has received two significant orders of TANGO and MATRIX-I FT-NIR (Fourier transform near infrared) spectrometers from leading animal nutrition companies in the People's Republic of China
Self-management education programs for people with chronic obstructive pulmonary disorder (COPD) significantly decrease hospital admissions, researchers report in a new systematic review of studies.
High levels of anxiety and depression among medical doctors have been recorded in a new cross-country study that finds Italian doctors most likely to have experienced mental health symptoms during the pandemic.
Researchers in the University of Arizona's BIO5 Institute have entered into a collaboration with Johnson & Johnson Consumer & Personal Products and Janssen Biotech Inc. to leverage foundational discovery research aimed at determining environmental factors that underlie asthma and allergies.
Aerie Pharmaceuticals, a biotechnology company focused on the discovery and development of novel treatments for glaucoma, today announced positive results from a Phase 2a study of its Rho-kinase (ROCK) inhibitor, AR-12286. The study evaluated the safety, tolerability and efficacy of three different doses of AR-12286 in 88 patients with primary open angle glaucoma or ocular hypertension.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chundra Brown Brooks, FNP 3320 Old Jefferson Rd Bldg 700, Athens, GA 30607-1465 Ph: (706) 353-2990 | Chundra Brown Brooks, FNP 658 N Chase St Ste 201, Athens, GA 30601-1960 Ph: (706) 353-2990 |
News Archive
Bruker Corporation today announced that it recently has received two significant orders of TANGO and MATRIX-I FT-NIR (Fourier transform near infrared) spectrometers from leading animal nutrition companies in the People's Republic of China
Self-management education programs for people with chronic obstructive pulmonary disorder (COPD) significantly decrease hospital admissions, researchers report in a new systematic review of studies.
High levels of anxiety and depression among medical doctors have been recorded in a new cross-country study that finds Italian doctors most likely to have experienced mental health symptoms during the pandemic.
Researchers in the University of Arizona's BIO5 Institute have entered into a collaboration with Johnson & Johnson Consumer & Personal Products and Janssen Biotech Inc. to leverage foundational discovery research aimed at determining environmental factors that underlie asthma and allergies.
Aerie Pharmaceuticals, a biotechnology company focused on the discovery and development of novel treatments for glaucoma, today announced positive results from a Phase 2a study of its Rho-kinase (ROCK) inhibitor, AR-12286. The study evaluated the safety, tolerability and efficacy of three different doses of AR-12286 in 88 patients with primary open angle glaucoma or ocular hypertension.
› Verified 9 days ago
Ms. Susan Gail Adams, APRN-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1905 Barnett Shoals Rd, Athens, GA 30605 Phone: 706-542-7053 | |
Ireta Favors, PMHNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 250 Bray St, Athens, GA 30601 Phone: 678-215-4907 Fax: 678-671-8489 | |
Melissa Bienacker Baughcum, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 340 N Milledge Ave Ste B, Athens, GA 30601 Phone: 706-548-0008 Fax: 706-369-9673 | |
Amanda Gunter, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1175 Mitchell Bridge Rd, Athens, GA 30606 Phone: 706-534-4637 | |
Lauren Gruendling, DNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 242 King Avenue, Suite 210, Athens, GA 30606 Phone: 706-475-1700 | |
Oyebisi Moriliat Kilani, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 240 Mitchell Bridge Rd, Athens, GA 30606 Phone: 770-910-9196 Fax: 770-910-9196 | |
Cheryl Y Reed, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2142 W Broad St Bldg 100 Ste 200, Athens, GA 30606 Phone: 706-548-6881 Fax: 706-546-0821 |